# A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects

> **NCT07126249** · PHASE1 · COMPLETED · sponsor: **Abbisko Therapeutics Co, Ltd** · enrollment: 38 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** pimicotinib capsules

## Key facts

- **NCT ID:** NCT07126249
- **Lead sponsor:** Abbisko Therapeutics Co, Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-13
- **Primary completion:** 2025-06-06
- **Final completion:** 2025-06-16
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07126249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07126249, "A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07126249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*